Nasal polyposis:most common tumor in nose & paranasal sinuses.


Note1:This is thevery alpha version of NYMU Med89 common note of ENT on Sep, 30.The content of this document may be altered

.

Note2:The document is virtually an enhanced version of my notes,so I do not pay much attention to the layout.

.
Áö»¡¤£¹³¡AÁÙ¬OÂk¦b¦¹Ãþ¡C¤j¦h¦b¤¤»ó¹D¡C
Symptom:¤j¦h¬°Âù°¼¡C¦p¬°³æÃä«h­n¦Ò¼{¨ì§OªºªF¦è¡C

N-O(»ó¶ë),rhinorrhea,hyposmia.¦]¶åı¦b¤W³¡¡A­Y®ð¬y¤£¨ì«h¤£¯à·Pı¡C¬Æ¦Ü¥i¨ìanosmia.»óÃ褣¤@©w¬Ý±o¨ì¡A¦³®É­nendoscope.

endoscopy:polyps in middle meatus.

CT:CT face:¤£¥Î¥´ÃÄ¡A´N¥i·Óaxial©Mcoronal view¦Ó¥i¬Ý¥ßÅéÃö«Y¡C ¥­±`ªºmucosa¦bCT¤W¬O¬Ý¤£¨ìªº¡A°£«D¦³hypertrophy or fluid.

¯fÅܦh¦bmiddle meatus¡A¬O¦]¬°«Ü¦hsinus¤Þ¬y¨ì³o¸Ì¡C¶ë¦í«hsinus±Æ¤£¥X¡A²Óµß²Ö¿n¡A®ñ®ð·|¤U­°¡C
Orbit¦³°ÝÃD¡A³Ì¦³Ãö«Yªº¬Oethmoid sinus¡C¦]¬°¨ä¶¡ªºªO«ÜÁ¡¡C¤â³N®É¤]¥i¯à¥Ñ¦¹¤£¤p¤ß¥´¤Jorbit¡C
³æ¿W¦s¦bªº¡A¦­´Á¤j·§µL¯gª¬¡A¨Öµo¨ä¥LªF¦è¡Ð¡]¥i¯à¦³¹L±Óªº¡A¦¨¦]¤£©ú¡^

ªvÀø¡G

  • Treat underlying disease
  • conservation treament:medication:¦psymptom¤£©úÅã¡B¦Ñ¤H¤p«Ä¡B§ïµ½¹L±Ó¡Bseptal deviation¡C
  • Surgery:FESS for CPS & polyposis Intranasal polypectomy:¥u®³®§¦×ºâ¬Oconservative.¦pªG¯f¤H¦³¨ä¥L°ÝÃD¡A´N¥i¯à¥u­n¨Dconservative.­n®³´N¤@©w­n±q¨¬®³±¼¡C
    Uncinate process¤À¹j¥Xmaxillary sinus. ¥H«e±Nmaxillary sinus¾ã­Ó³s®§¦×®³±¼¡A¦ýethmoid sinus²M¤£°®²b¡C ²{¦b»{¬°¯f·½¦bant. ethmoid sinus¡A¬Gmaxillary sinus¤£¤@©w®³±¼¡A¦Ó¥Îendo¶i¥h¤Áuncinate ¡A¥´¤j¥X¤f¡A¦V¤W®³±¼ethmoid sinus¡A¥´¤jfrontal¥X¤f¡C¤¤»ó¥Ò­n¬O¤Ó¤j©Î¦³°ÝÃD¤]¥i®³±¼¡C
    Middle turbinate syndrome:¤¤»ó¥Ò­×°Å¤@¯ë¨Ã¤£¤Þ°_atrophic rhinitis¡A¦]¬°¥D­n¥\¯à¬O¦b¤U»ó¥Ò¡C
    D.D.:with other tumors,esp.inverted papilloma...polyp¸û¤ô¼Ë¡B¯»¬õ¡C

    Inverted papilloma--

  • papilloma¬Oepitheliumªº¡A¥þ¨­³£¦³¡C
  • Inverted papilloma:¸ûµw¡B¦Ç¡A¦h¬°³æÃä¡C
    1854¥ÑWard­º¦¸´y­z¡C***¦b1971¤À¥X¡G
  • inverted papilloma
  • fungiform papilloma
  • cylindrical papilloma ±`¨Ö¦³´c©Ê¡A¤]¦³´c©Êªº¶É¦V¡C¨äbasement membrane intact,¬G¥»¨­¬O¨}©Êªº¡C¦ý¥i¦V´c©ÊÂàÅÜ¡A©Î¨Ö¦³´c©Ê¯fÅÜ¡C

    Clinical feature:

  • ¥D­n¦b¤¤¦~¡A¨k¡G¤k=2:1 or 3:1
  • ¥D­n¬O³æÃ䪺N-O
  • Epistaxis
  • Pain
  • Location:lateral nasal wall,usu. in middle meatus & turbinate(¤@¯ëtumor¦h¥X¦Ûlat. wall¡C¡^
    ¥²°O¤§... ¯S¼x
  • local recurrence
  • local destruction
  • malignant transformation or associated with Ca
  • multientric lesion
  • (w/ malig. change:pathology¤W¥i¨£ºCºCÅܤơFC' w/ malig.:¦³clear cut of benign & malig.)

    High risk factor:

  • HPV
  • incidence of squamous cell Ca:5~15%
  • Dx:sono,endoscope,CT:
  • CT most useful in Diagnosis & plan of resection(¹ïbone,CT¤ñMRI¦n¡F¹ïsoft tis.,MRI¸û¨Î¡C¡^
  • ­nlongterm follow up with endoscopic & CT examination.Recurrent rate«Ü°ª¡C
    MRI¤]¦b¬y¦æ¤¤¡A¦ý¤£·|¥Î¦b²Ä¤@½u¡A¦]¬°1.°·«O¤£¤Ó±µ¨ü¡A¯f¤H¤]ıªá®É¶¡2.CT¥i¬Ýaxial view©Mcoronal section¡A¨Ã¥i¬Ýboneªº±¡ªp¡C¦pmaxillary sinus,ethmoid sinus,frontal sinusµ¥³£¦³»Ý­n¡C¦]¬°¹ï°©ÀY¡ACT¤ñMRI¦n¡F¹ïsoft tissue,MRI¸û¨Î¡A¬G¦bsaggital section¡]¤¤½uªþªñ¡^ªºtumor¤Îbrain tumor¡AMRI·|¦³¥Î¡F¦ý¦pinverted papilloma,malignant osteomaµ¥µ¥ªº¶EÂ_¡B¤â³N­pµe¡B°lÂÜ¡A´N¥ÎCT´N°÷¡C¡C ¤@©w­nlongterm follow up with endoscopic & CT ¦]¬°recurrent rate«Ü°ª¡C ±µ¤U¨Ó¬O¤@±iCT¡A®v¤ª»á¤j¡A¶ë¦í¬ÛÃöªºsinus¡A¼vÅT¥\¯à¡C

    Surgery:

  • medial maxillectomy
  • Lateral rhinotomy
  • Functional endoscopic sinus surgery(FESS)
  • Middle facial degloving(¹ï¥I¤¤½uªºtumor¡A¥Ñ¤f¤U¤J¡A¤Ágingiva¦V¤W¤Á¡C).
  • R/T for Ca.
    ¥H«e²Î­p¡Aconservative surgery ¤§recurrent rate «Ü°ª¡A©Ò¥H°µ¤ñ¸ûradicalªº¤â³N¡A¦pmedial maxillectomy,lateral rhinotomy¡A©Î¬Omiddle facial degloving¡C
    Middle facial degloving¬Otumor¦b¸û¤¤½u¡B»ó¤l¡Bnasal floorªþªñªÌ¡A¥i¥Ñ¤fµÄ¼L®B¤U­±¶i¥h¡A¤Ágingiva¶}¡A½¶}¡A©¹¤W¡A±N¾ã­Ónasal floor,maxillary floor,tumor¼ÉÅS¥X¨Ó¡C¾A¥Î©ó¤¤½uªþªñ¸û§C¦ìªº¸~½F¡C
    lateral rhinotomy:±q°¼»ó¤Á¶i¥h¡A¤ñ¸û«]­­©ó»ó©³³¡ªº¸~½F¡C
    medial maxillectomy¡G±N»ó¤l¡Bmaxillary sinus¥þ²M±¼¡C
    ¥t¥~¦Ñ®vmurmur¤F­Ó¸û¤pªº¤â³N¡A¾A¥Î©ó¸ûÅ¥¸Ü¡B¯à±K¶°½T¹ê°lÂܪº¯f¤H¡C
    ¤Á¤U¨ÓªºªF¦è¤ñ¸ûµw¡B¶Â¡B¤£³z©ú¡C¤£¨º»ò¤ô¤ôªº¡C

    Recurrent rate:

    limited excision:28~78% §Ú­Ìªºrecurrent rate«D±`§C¡A¦]¬°§Ú­Ì°µªº«Ü¹ý©³¡C³Ìªñ¥ÎFESS¡A¹ï¸ûlimitedªºpapilloma®ÄªG¤]«Ü¦n¡C ¯f²z³ø§i¬OCa.¡A«h­n¦A°µ¹W60·Ó®g¡C

    Osteoma

    (malig.¥Heth.©Mmax.¬°¦h¡Ffrontal¤§malig.¸û¤Ö¡^
  • frontal sinus:80%
  • ethmoid sinus:16%
  • maxillary sinus:rare
    °©½F©Minverted papilloma¤£¦P¡A¥Hfrontal sinus¸û¦h¡]frontal sinusªºmucosa¬Opeudostriated epithelium¡A©M»ó¤l¤@¼Ë¡F°©¾À«h¦Usinuses¤@¼Ë¡C¬°¤°»ò³o¸Ì¸û¦hosteoma¡A¤£ª¾¹D¡^¡CSinuses¤¤¡Afrontal sinus¦û¸û¦hªº¡A¬Oosteoma©Mmucocele¡Ffrontal sinusªº´c©Êªº«Ü¤Ö¡C´c©Ê¸û¦hªº¬Oethmoid & maxillary sinuses¡Ffrontal & sphenoid sinusesªº¯f«Ü¤Ö¡C

    Symptom

  • mostly asymptomatic
  • incidentica; finding on XR
  • headache,orbit symptoms
  • N-O,CSF leakage
    °©½F«Ü¤Ö¦³¯gª¬¡C¦]sinus¬°ªÅµÄ¡A¦Ó½F±q°©¾Àªø¥X¨Ó¡A¤pªº´N¤£µo¥Í¯gª¬¡A­nªø¤j¨ìÀ£­¢¨ì¤~·|¦³¯gª¬¡C±`±`¬OÅéÀˮɵo²{ªº¡C
    ¦³¯gª¬¡A¤j·§´N¬OÀ£­¢ªº¡A¦pÀYµh©Î¬O²´²y¯gª¬¡C¦A¤j´N¥i¯à³y¦¨»ó¶ë¡A©Î¬Ofrontal sinus¦³lesion¡A³y¦¨CSF leakage¡A·P¬Vªº¸Ü·|³y¦¨¸£½¤ª¢¡Bbrain abscessµ¥¯gª¬¡Ð³o®É·íµM½F¤w¸g«Ü¤j¡C

    Type

  • Ebumated type uniformly radiodense
  • Canullous type bony rim with radiolucent center ¥i¤À¬°¨â«¬¡ACT¤W¬Ý°_¨Ó¤£¤@¼Ë¡CCanullous type®ÇÃä¬Obony rim¡A¤¤¶¡¬Oradiolucentªº¡Febumated type«h¾ã­Ó¬Oradiodenseªº¡C°£«D«Ü¤j¡A§_«h¥~ªí¬Ý¤£¥X¨Ó¡C
    ¤@¯ë¶©°_¤ñ¸û¦hªº¬Omucocele¡A¦]¬°¥¦·|¸~¤j¡A¦Y°©ÀY¡Aº¥º¥ªº´N·|¹ª°_¨Ó¡A¬Æ¦ÜÀ£­¢¨ì²´²µ¡C.Mucocele¤]¬Ofrontal¸û¦h¡C

    Tx:

    Asymtomatic: follow up. Sugery: frontal sinus:osteoplastic flap ¤@¯ë¥Î¦¹¡C¡]ÀY¥Ö½¤U¡A¶}frontal sinus¡A§âbone¾ã­Ó¿i±¼¡A®³±¼osteoma¡F­Yfrontal sinus¦V¤Uªº¤Þ¬y¨}¦n¡A´N¯dµÛÅý¥¦¤Þ¬y¡Fdrain¤£¦n¡A±q¨{¤l®³fat,®³±¼mucosa¡A¾ã­Ó¶ñ°_¨Ó¡C®v»¡¡A¤£­n¥þ¶ñ¡A­n¯dobturator¥HÆ[¹î¡CFat¬O§_¶È¬°¬üÆ[¤§¥Î¡H¡^ ethmoid sinus:ext. ethmoidectomy maxillary sinus:C-W-L operation
    Frontal osteoplastic approach best for tumor mapping ¹ïosteoma,mucocele,frontal sinusªºmaligancy or tumor¬Ò¾A¥Î¡]¥H¤U¤TÂI¥¼§Û¨ì¡^¡C

    Mucocele of Nose & Paranasal Sinuses

    Mucocele

    :accumulation & retention of mucoid within a sinus. If infected--pyocele
    Mucocele¡G­ì¦]¤£©ú¡A¥i¯à¬Omucoidº¢¯d¦bsinus¤¤¡F­Y¦³·P¬V´N¥spyocele¡C

    Etiology:

  • trauma
  • infection
  • duct or orifice obstruction
  • mucosa gland hyperplasia ¥Ø«e´£¥Xªº°²»¡¦p¤W¦C¡C
    Mucous gland¥»¨­ºCºC¼W¥ÍÅܤj¡A¨ä¤¤ªº²GÅé°ï¿n¡AºCºCÅܤj¡A²£¥Ímucocele¡CÅܤj«áÀ£¨ì®ÇÃä²Õ´´N·|²£¥Í¯gª¬¡C¤]¦³¤H¥H¬°¬Osinusªº¥X¤f°ô¶ë¡A¤Þ¬y¤£¨Î¦Ó­P²GÅé°ï¿n©Ò³y¦¨¡C

    Symptom:

  • periorbital swelling(¦]¾a¦bfrontal)
  • proptosis
  • diplopia
  • N-O(¸û¤Ö¡^¡]°£eth.¤§mucocele«Ü¤j¤~·|involve N-O)(p't¦h¥ý§ä²´¬ì¦Arefer¨Ó¡^

  • Frontal-60%
  • Ethmoid-30%
  • Maxillary-10%
    ¦]¥D­n¦bfrontal sinus¡A¬G¥D­n¯gª¬§Y²´²µ¬ÛÃö¤§¯gª¬¡A¦p frontal sinusªþªñ·|ÀYµh¡A²´²µ¦³À£­¢¡Ð¡Ðperiorbital swelling,proptosis,¡]²´²y¬ð¥X¡^dipopia¡C»ó¶ë¤ñ¸û¤Ö¡A°£«Dethmoid sinusªºmucocele«Ü¤j¡C©Ò¥H¯f¤H¦h¥ý§ä²´¬ì¦Arefer¨Ó¡C

    D.D. with malignancy:

      ¨ä¬°homogenous destruction¤£¬O«Ü¼F®`¡]ÁöµM¦³bony erosion¡A¦ýÁÙ¬O¤£ºâ«Ü¼F®`¡C¡^ ¨ä¬°¿±µÈ«¬(expansile)lesion¡A¦Ó¤£¹³tumorªºbehavior¡C

    Tx

    :surgical intervention
  • Frontal sinusotomy
  • Lynch approach
  • Osteoplastic & fat reconstruction
  • Mucoperiosteal flap
  • (°Ê¤M®ÉÁ_­ÓªF¦è«OÅ@orbit.±`¥Îscope F/U)
    ¥H«e¥ÎLynch approach¡Arecurrent rate»á°ª¡C¦]¨ä¬O°µethmoidectomy¡A§âethmoid sinus¦V»ó¤lªº¤Þ¬y¥´¤j¡A®³±¼mucocele¡C¦ýethmoid sinus¤§¤U¡A¦V»ó¤l¤§³B±`¤S°ô¶ë¡A´N¤S´_µo¡C
    ¬G±`¥Îosteoplastic approach¡A¥Îfat¶ñ¶ë¡A©Î¥Îmucoperiosteal flap¨Ó§@­««Ø¡F³o´N¬O¦b»ó¤lseptumªºlateral wallªºÂH½¤¤Á¹L¥h¡A©ñ¨ìfrontal sinus¡C¥Hºû«ù§Îª¬¡C
    ±µ¤U¨ÓÁ¿¸Ñ¤@¨Çflap¡A¦Ñ¹êÁ¿¡A¤W½Ò´NÅ¥¤£©ú¥Õ¡C¦Ñ®v´£¨ì¥Îflapªº²z¥Ñ¡G­n¬O¹³¥H«e°µfrontal ethmoidectomy¡AÁöµM¶}±o«Ü¤j¡A«o±`·|¤S¾ã­Ó°ô°_¨Ó¡A¦³flap¤W¥h¡A¥¦·|ºCºCªø¤U¨Ó¡A¦å²G¨ÑÀ³«Ü¦n¡A´N¤£·|¤S°ô¶ë¡C¦pmucocele«Ü¤j¡A´N­n°µ¨âÃ䪺flap¡C
    «e´£¬Oethmoid³oÃä­n¥´±o«Ü§C¡A­n¸ò»ó¤l¦P¼Ë¤ô¥­¦ì¸m¡Ffrontal sinus floor­n¥´±o«D±`§C¡A¤~¤£·|¹³¤ôÅò¤@¼Ë¤S»W¿n¦bsinus¸Ì­±¡C
    Mucoceleªºmucosa±`«ÜÁ¡¡C
    ²´²µ¨ºÃä­n¥ýÂ\­ÓªF¦è«OÅ@¡A¥ýÁ_­ÓªF¦è«OÅ@µÛ¡A¤§«á­n·F¤°»ò³£¦w¥þ¤@ÂI¡C ¦Ñ®v¤S´£¨ì¤@­Ó¯f¨Ò¡A·Ócoronal section¡A±N¤ù¤l®ø¬r¡A´N¶K¤W¯f¤H¨­¤W§@mapping¤§¥Î¤F¡C¤p¤ßªº¬O¶}±o¤Ó¤p©TµM¤£¦æ¡A¤Ó¤j¤S·|¨ì¸£¤l¸Ì­±¥h¡K¡C
    ©Ò¥H°Ê¤M®É°£¤w¦³¤§¼v¹³¥~ÁÙ­nºV¡Gfrontal sinusÁn­µ²M¯Ü¡A¸£¤lÁn­µ²V¿B¡C
    ²Mmucosa¡C±Nmucocele²M°®²b«á¡A¬Ý¬Ý·P¬V¡Bdrainage¡Bmucosa¥\¯à«ç¼Ë¡C·P¬VÄY­«¤Sªý¶ë¡A´N±q¨{ÂÀªþªñ¨ú¯×ªÕ¸É¤§¡F­n¬O·P¬V¤£«ç»ò¼Ë¡Amucosa lining¡Bdrainage«Ü¦n¡A´N¯dµÛ¡C
    ÀY¾v­Ë¤£¤@©w­n«c¡F¬~°®²b­Ë¬O­n¡C
    ¤@©w­n¸g±`§@scope¶i¥hfollow up¡A¬Ý¬Ý¤Þ¬y¦p¦ó¡B¦³µL´_µo¡C¥Îscope follow up ¬O«Ü­«­nªº¡A¹ï¨ä¥L¦p¶}Caµ¥¥ç¦P¡C¥H¨D¦­´Á³B²z´_µo¡C

    Ca. of Nose:

    ¤ñsinus¤Ö¡CVGH20¦~¶È36­Ócase.
  • peak age:50-69y/o
  • male>female

    Symptom:

  • Symptom-->Dx:4.5mos
  • N-O(nasal obstruction):55.9%
  • Epistaxis:(38.9%)
  • Neck mass(27.8%)(¦]lymph drainage¤ñsinus¬°¦h¤§¬G¡C
    meta.³Ì¦hªº¦a¤è¡Fsubmandible gland&retropharyngeal LN.¨ä¤¤submandible gl.¤§meta. tumor­n·Q¨ìªº¡G1.nose;2.¤fµÄ¤ºªºCa.¦ÓNPC¬O¨ìupper jugular LN or post.triangle LN.Mid. jugular «h¬Othyroid Ca.±`Âಾ¥hªº¡Ð¡Ðµo²{³o­Ó¦³®É¦bthyroidªºtumorÁ٫ܤp¬Æ©ÎÃø¥HÀË¥X¡C¡^

    History:

  • sqoamous cell Ca³Ì¦h
  • undifferentiated cell Ca.
  • olfactory neuroblastoma
  • malignant lymphoma
    ­n¦n¦n°Ý.Nose¤ñsinus¦n´N¦n¦b¯gª¬¦­¥X²{¡AÀˬd¤]¸û©ö¡C¤£¹LÁÙ¬O­n¤p¤ß¬Ý¡C

    Tx

    :surgery & R/T
    (­Y¶·®³palate®É­n¥Ñ¤ü¾¦¤§«á¶}©l®³¡Aª`·Nªù­±¬üÆ[¡C¡^

    Nose Ca. vs Sinus Ca

    .
    Nose:
  • earlier Dx
  • Tx rather easy
  • Prognosis better
  • Smaller cases(case¸û¤Ö¤§·N¡^

    Lethal Midline Granuloma:

    Nose¤§¤¤½u¦³º¥¶i©Êªºdestruction,¤º¦³disfunction tis.¯ä¡Apus.
    Nose,sinuses,palate¤§¤¤½u¬Ò¦³¯f¨_¡A¦pµoª¢¯ë¡C¥H«e§Þ³N¤£¨Î¡A¦Ó´Nºâ¦³tumor¡A±`±`¤]¤w¸gÄê¤F¡C

    Character:

  • Progressive ulceation & destruction of midfacial tissue
  • More in Oriental
  • Proven to be malignant lymphoma,espcially T-cell lymphoma.
  • Nose mostly involved(86%);sinus(10%)
  • ¨k©Ê¸û¦h¡]2¡G1¡^
  • mean age:male42:y/o;female38:y/o

    Symptom:

  • N-O
  • Purulent or bleeding discharge
  • Midfacial destruction
  • Cheek numbness & swelling
  • Orbital symptoms
  • Fever or body weight loss

    Dx:

  • CT
  • Repeat biopsy:¥²­n¡C²M±¼ÄêÄꪺ¡A¨úfreshªº¡A¨Ãrepeat.
  • Staging of malignant lymphoma
  • ¡]¥H«e¥Îhistology¨£acute inflamation¤Î®asteroid-->fever­°¤F¡C²{¥u­n¥Î²Õ´¤Æ¾Ç§Yª¾¡C¡^

    Tx:

  • R/T:4500-5000cGY.High dose did not improve result.
  • C/T
  • Systemic µ¹steroid
  • Nose¥iµ¹spray¥Hrelieve Sx.

    Prognosis:

  • Initial response to R/T is good.
  • Resolution of symptom is good.
  • Prognosis related with staging.

    Sinus malignancy:

  • 0.2~0.8% of all malignancies(¥e¤W©I§l¹Dªº3¢H¡^
  • squamous©~¦h¡A¥e60¡ã80¢H¡^
  • minor salivatary tumor
  • peak age:50~69y/o
  • male>female
  • ¥D­n¦bmaxillary sinus¡Cfrontal sinus¤Ö¤§¡C
  • ¶È15.4¢H«]­­¦b¤@sinus¡C¨ä¥Lªº¦bµo²{®É¤winvolve¨â­Ó¥H¤W¡C

    Sx.:

  • Unilateral N-O
  • Epistaxis
  • Headache
  • Numbness of cheek
  • Diplopic
  • Epiphora

    Sign

  • Tumor in nose
  • Proptosis
  • Ulcer in palate
  • Cheek swelling
  • (³£¬O«á¨ÓÀ£­¢©Ò­P¡^

    Dx.:

  • High suspicion of patient and doctor
  • Through PE(¦p³æÃä¡B³Â¡B¤ú¾¦ÃP°Êµ¥¡^
  • Sinus sonogram
  • CT
  • Sinuscopy¡]scope¥²­n¬Ý¡^
  • Biopsy
  • ¥²¶·½T©w¤£¬OCa.¤~¯à©ñ¤ß¡C
  • Symptom-->Dx.:6~12mos
  • ¦³®ÉCT¨£¤w¶i¸£¦ýÁÙ¬O¶}¡C¦]¬°dura«Üµw,tumor¥¼¥²¤w¦Y¶i¥h¡Ð¡ÐÁöµM¦³®É¤wªþµÛ¤F¡C¡^
    Ohngren's line

    lederman:¤À

  • suprastructure
  • mesostructure
  • infrastructure--best Prog.

    Tx.:

  • R/T along
  • R/T+surgery
  • R/T,minor surgery & infraartery infusion
  • Surgery:maxillectomy £ror s orbit craniofacial resection
  • Rehabitation
  • Prosthesis

    Surgery:

  • incision
  • palate-->¤ú¾¦«ç»ò¯d
  • inf. temporal fossa
  • skull base
  • orbit
  • nasolacrimal sys.-->¦]¤U­±ªºªF¦è·´¤F¡A©Ò¥H­n³]ªk¨Ï²´²\¬y¤U¨Ó¡C

    Indication of orbit enucleation

  • Orbital fat involved
  • E.O.M involved
    5yr survival:21.3% 10yr survival:6.6% ¡Ð¡Ð¡Ð¤£¹L³Ìªñrecurªº¤Ö«Ü¦h¤F¡C

    Prognosis due to

  • Advanced stage at time of Dx.
  • Complex anatomy
  • Less aggressive Tx

    High Suspicion of Patient & Physian

  • ­n¸ò¯f¤H¦n¦n·¾³q
  • ²´²\­n¤Þ¬y
  • Fine osmetic
  • Obturator

    Jay M. Yang. Last updated : ¬P´Á¤T, 1997¦~10¤ë1¤é
    [email protected]
    Hosted by www.Geocities.ws

    1